InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Lucas Kenan, Director. Director active across 2 companies, notably Qumu Corp. In total, 7 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €1.5m. History available since 11 August 2021. The latest transaction was filed on 12 August 2025 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lucas Kenan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
321,614 shares@ US$5.3456.7% of flowCommon Stock, $0.01 par valueSEC:0000919574-25-004947:0
250,000 shares0Common Stock, $0.01 par valueSEC:0000919574-24-004081:0
58,066 shares@ US$0.906.3% of flowCommon Stock, $0.01 par valueSEC:0000919574-23-000924:0
757,575 shares@ US$1.3278.9% of flowCommon Stock, $0.01 par valueSEC:0000919574-22-006133:0
Canonical exit: 24 Jan 2023 (T+90)
14,967 shares0Common Stock, $0.01 par valueSEC:0000919574-22-003772:0
100,000 shares@ US$1.505.1% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-007515:0
Canonical exit: 16 Mar 2022 (T+90)
175,000 shares@ US$2.444788.2% of flowCommon Stock, $0.01 par valueSEC:0000919574-21-005215:0
Canonical exit: 9 Nov 2021 (T+90)
7 of 7 declarations
About Lucas Kenan
LUCAS KENAN is Administrateur and a Director at Streamline Health Solutions INC. and Qumu Corp. He has 7 filings in total, and in the recent filings observed, buys amount to EUR 1488096 and sells to EUR 0, between 2021-08-13 and 2025-08-14, with the dominant transaction nature indicated as Acquisition.
